Last video

Right robotic partial nephrectomy after 3D reconstruction

View all videos

Week Article

  • Is cytoreductive nephrectomy relevant in the immunotherapy era?

    The recent approval of immune checkpoint inhibitors (ICI) revolutionized the treatment paradigm for metastatic renal cell carcinoma (mRCC). However, the role of cytoreductive nephrectomy is not well defined in this setting. Here, we review the contemporary role and timing of cytoreductive nephrectomy for advanced RCC in the era of immunotherapy. ...

View all articles

About us

The LARCG (Latin American Renal Cancer Group) is a group of scientific and educational, multicentric, multidisciplinary and independent. It is not for profit, and the term of operation is indeterminate. It consists of Urologists, Pathologists and Oncologists, as well as professionals and researchers related to the field of health, belonging to Hospitals in Latin America, Spain and the United States.

Read more

Last Tweets

Data from our patients with mRCC submitted to metastasectomy!
⁦@acccancercenter⁩ ⁦@StenioZequi⁩ ⁦⁦@AldoLADETTINO⁩ ⁦@Isabelawcunha⁩ ⁦@WalterCosta⁩

New: ESMO 2019 Highlights for #kidneycancer patient organisations from the International Kidney Cancer Coalition #ESMO19

Briefly two new papers in RCC:PDL1 expression in more than 1000 cases, from AC Camargo, @larcg_org Lee Moffitt @SpiessPhilippe Juan Chipollini.
And bad prognostic in negative Ezrin expression in 575ccRcc, from @acccancercenter @larcg_org Proud!

Load More...



You don't have permission to register